ABBOTT LABORATORIES Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax
ABBOTT LABORATORIES (ABT) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax of -$27.00 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax · last filed 2016-11-03
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2016-09-30 was -$27.00M, a 437.50% decline year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2016-06-30 was -$8.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2016-03-31 was -$89.00M, a 442.31% decline year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for the quarter ending 2015-12-31 was -$44.00M, a 222.22% decline year-over-year.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2015 was -$35.00M, a 137.23% decline from fiscal 2014.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2014 was $94.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2013 was -$53.00M.
- ABBOTT LABORATORIES other comprehensive income (loss), derivatives qualifying as hedges, net of tax for fiscal 2012 was -$118.00M, a 206.31% decline from fiscal 2011.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 6 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 9 month as first filed | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-09-30 | -$27.00M 10-Q · filed 2016-11-03 | -$35.00M derived: sum of 2 quarters · filed 2016-11-03 | -$124.00M 10-Q · filed 2016-11-03 | -$168.00M derived: sum of 4 quarters · filed 2016-11-03 | ||||
| 2016-06-30 | -$8.00M 10-Q · filed 2016-08-03 | -$97.00M 10-Q · filed 2016-08-03 | -$141.00M derived: sum of 3 quarters · filed 2016-08-03 | -$133.00M derived: sum of 4 quarters · filed 2016-11-03 | ||||
| 2016-03-31 | -$89.00M 10-Q · filed 2016-05-04 | -$133.00M derived: sum of 2 quarters · filed 2016-05-04 | -$125.00M derived: sum of 3 quarters · filed 2016-11-03 | -$150.00M derived: sum of 4 quarters · filed 2016-11-03 | ||||
| 2015-12-31 | -$44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$36.00M derived: sum of 2 quarters · filed 2016-11-03 | -$61.00M derived: sum of 3 quarters · filed 2016-11-03 | -$35.00M 10-K · filed 2016-02-19 | ||||
| 2015-09-30 | $8.00M 10-Q · filed 2016-11-03 | -$17.00M derived: sum of 2 quarters · filed 2016-11-03 | $9.00M 10-Q · filed 2016-11-03 | $45.00M derived: sum of 4 quarters · filed 2016-11-03 | ||||
| 2015-06-30 | -$25.00M 10-Q · filed 2016-08-03 | $1.00M 10-Q · filed 2016-08-03 | $37.00M derived: sum of 3 quarters · filed 2016-08-03 | $102.00M derived: sum of 4 quarters · filed 2016-08-03 | ||||
| 2015-03-31 | $26.00M 10-Q · filed 2016-05-04 | $62.00M derived: sum of 2 quarters · filed 2016-05-04 | $127.00M derived: sum of 3 quarters · filed 2016-05-04 | $120.00M derived: sum of 4 quarters · filed 2016-05-04 | ||||
| 2014-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $101.00M derived: sum of 2 quarters · filed 2016-02-19 | $94.00M derived: sum of 3 quarters · filed 2016-02-19 | $94.00M 10-K · filed 2016-02-19 | ||||
| 2014-09-30 | $65.00M 10-Q · filed 2015-11-05 | $58.00M derived: sum of 2 quarters · filed 2015-11-05 | $58.00M 10-Q · filed 2015-11-05 | |||||
| 2014-06-30 | -$7.00M 10-Q · filed 2015-08-04 | -$7.00M 10-Q · filed 2015-08-04 | ||||||
| 2013-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$30.00M derived: sum of 2 quarters · filed 2016-02-19 | -$33.00M derived: sum of 3 quarters · filed 2016-02-19 | -$53.00M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$11.00M 10-Q · filed 2014-11-06 | -$10.66M 10-Q · filed 2013-11-07 | -$14.00M derived: sum of 2 quarters · filed 2014-11-06 | -$34.00M 10-Q · filed 2014-11-06 | -$34.16M 10-Q · filed 2013-11-07 | -$66.92M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | -$3.00M 10-Q · filed 2014-08-05 | -$2.57M 10-Q · filed 2013-08-06 | -$23.00M 10-Q · filed 2014-08-05 | -$23.49M 10-Q · filed 2013-08-06 | -$55.92M derived: sum of 3 quarters · filed 2015-02-27 | -$99.97M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | -$21.00M 10-Q · filed 2014-05-07 | -$20.92M 10-Q · filed 2013-05-08 | -$52.92M derived: sum of 2 quarters · filed 2015-02-27 | -$96.97M derived: sum of 3 quarters · filed 2015-02-27 | -$93.81M derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | -$31.92M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$75.97M derived: sum of 2 quarters · filed 2015-02-27 | -$72.81M derived: sum of 3 quarters · filed 2015-02-27 | -$118.00M 10-K · filed 2015-02-27 | -$117.67M 10-K · filed 2013-02-15 | |||
| 2012-09-30 | -$44.06M 10-Q · filed 2013-11-07 | -$40.89M derived: sum of 2 quarters · filed 2013-11-07 | -$86.08M 10-Q · filed 2013-11-07 | |||||
| 2012-06-30 | $3.16M 10-Q · filed 2013-08-06 | -$42.02M 10-Q · filed 2013-08-06 | ||||||
| 2012-03-31 | -$45.19M 10-Q · filed 2013-05-08 | |||||||
| 2011-12-31 | $111.00M 10-K · filed 2014-02-21 | $83.20M 10-K · filed 2013-02-15 | ||||||
| 2010-12-31 | $128.68M 10-K · filed 2013-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |